Drugs · Brain health technique

Menopausal hormone therapy (MHT, HRT)

Evidence grade: Context Dependent

Illustration for Menopausal hormone therapy (MHT, HRT)

Systemic estrogen (usually estradiol via transdermal patch, gel, or oral form) combined with progesterone (micronized or dydrogesterone) for women with a uterus, used to relieve menopausal symptoms and support bone, vascular, and potentially brain health.

Practice
Drugs
Principle
Treatment
Tactic
Hormonal Therapies
Health domains
hormonal
Evidence grade
Context Dependent
Strength of evidence
Medium
Cost
High
Effort
Low
Time commitment
Low

How to practice Menopausal hormone therapy (MHT, HRT)

For healthy women under 60 or within 10 years of menopause, transdermal estradiol (0.025–0.05 mg/day) with oral or vaginal progesterone is safest. Use lowest effective dose and review annually. Avoid oral estrogen in high VTE risk. Do not initiate after age 65 without individualized assessment.

The evidence behind Menopausal hormone therapy (MHT, HRT)

When estrogen drops at menopause, your blood vessels stiffen faster and your bones thin faster. Hormone therapy replaces some of the estrogen you've lost. The evidence is strong that hormone therapy eases hot flashes, protects your bones, and relieves vaginal dryness and urinary symptoms caused by low estrogen. Clinical trial data and long-term studies suggest the benefits are greater when therapy starts within 5 to 10 years of menopause, while your blood vessels are still healthy.

Impact on brain health

Losing estrogen may also speed up cognitive decline. Estrogen supports synaptic plasticity, glucose use, and blood flow in the brain, which in theory could protect it. But there's no solid evidence from clinical trials to recommend hormone therapy just to prevent Alzheimer's, and any protection against brain aging is unproven and based on early, limited data.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing